Market Value4,583,149,000
Total Holdings96
File Date2022-05-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CVRX / CVRx, Inc.
WVE / Wave Life Sciences Ltd.
PHAT / Phathom Pharmaceuticals, Inc.
IPSC / Century Therapeutics, Inc.
NTRA / Natera, Inc.
VERV / Verve Therapeutics, Inc.
KALV / KalVista Pharmaceuticals, Inc.
FVAM / 5:01 Acquisition Corp.
CYT / Cyteir Therapeutics, Inc.
TGTX / TG Therapeutics, Inc.
KDNY / Chinook Therapeutics Inc
ARYE / ARYA Sciences Acquisition Corp V - Class A
BMEA / Biomea Fusion, Inc.
BIIB / Biogen Inc.
SPRY / ARS Pharmaceuticals, Inc.
AVTE / Aerovate Therapeutics, Inc.
DALS / DA32 Life Science Tech Acquisition Corp - Class A
OLMA / Olema Pharmaceuticals, Inc.
CGEM / Cullinan Therapeutics, Inc.
PNT / POINT Biopharma Global Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
OTIC / Otonomy Inc
TNYA / Tenaya Therapeutics, Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
KNTE / Kinnate Biopharma Inc.
HSAQ / Health Sciences Acquisitions Corp 2
VOR / Vor Biopharma Inc.
CCXI / Churchill Capital Corp XI
ANTX / AN2 Therapeutics, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
PARDES BIOSCIENCES INC / (69945Q105)
ZGNX / Zogenix Inc
NAUT / Nautilus Biotechnology, Inc.
CMPX / Compass Therapeutics, Inc.
ATXS / Astria Therapeutics, Inc.
AKUS / Akouos Inc
PMVP / PMV Pharmaceuticals, Inc.
FLACU / Frazier Lifesciences Acquisition Corp - Units (1 Ord Share Class A & 1/3 War)
GRPH / Graphite Bio, Inc.
/ LIANBIO
XLO / Xilio Therapeutics, Inc.
/ Cue Health, Inc.
PHAS / PhaseBio Pharmaceuticals Inc
IKNA / Ikena Oncology, Inc.
MORF / Morphic Holding, Inc.
MIST / Milestone Pharmaceuticals Inc.
MRTX / Mirati Therapeutics, Inc.
VERA / Vera Therapeutics, Inc.
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
RLMD / Relmada Therapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc.
MGNX / MacroGenics, Inc.
DICE / DICE Therapeutics Inc
KALA / KALA BIO, Inc.
PCVX / Vaxcyte, Inc.
CNCE / Concert Pharmaceuticals Inc
IOBT / IO Biotech, Inc.
ETNB / 89bio, Inc.
BOLT / Bolt Biotherapeutics, Inc.
RLAY / Relay Therapeutics, Inc.
CTKB / Cytek Biosciences, Inc.
CCCC / C4 Therapeutics, Inc.
NKTX / Nkarta, Inc.
LRMR / Larimar Therapeutics, Inc.
GH / Guardant Health, Inc.
ELYM / Eliem Therapeutics, Inc.
SYBX / Synlogic, Inc.
STSA / Satsuma Pharmaceuticals Inc
TIL / Instil Bio, Inc.
SCPH / scPharmaceuticals Inc.
TCRX / TScan Therapeutics, Inc.
CLDX / Celldex Therapeutics, Inc.
BLSA / BCLS Acquisition Corp - Class A
SLDB / Solid Biosciences Inc.
FMTX / Forma Therapeutics Holdings Inc
ENTX / Entera Bio Ltd.
IVVD / Invivyd, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
SYRS / Syros Pharmaceuticals, Inc.
TNGX / Tango Therapeutics, Inc.
COGT / Cogent Biosciences, Inc.
PYXS / Pyxis Oncology, Inc.
CNTB / Connect Biopharma Holdings Limited
NVAX / Novavax, Inc.
ALVR / AlloVir, Inc.
IMGN / ImmunoGen, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
ASND / Ascendis Pharma A/S
TYRA / Tyra Biosciences, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
ABOS / Acumen Pharmaceuticals, Inc.
TVTX / Travere Therapeutics, Inc.
JANX / Janux Therapeutics, Inc.
GHRS / GH Research PLC
RNA / Atrium Therapeutics, Inc.
ENTA / Enanta Pharmaceuticals, Inc.
HOWL / Werewolf Therapeutics, Inc.
RXST / RxSight, Inc.
EYPT / EyePoint, Inc.
ICVX / Icosavax, Inc.
DSGN / Design Therapeutics, Inc.
BLU / BluEnergies Ltd.
GERN / Geron Corporation
DYN / Dyne Therapeutics, Inc.
BDTX / Black Diamond Therapeutics, Inc.
ITOS / iTeos Therapeutics, Inc.
EWTX / Edgewise Therapeutics, Inc.